All News

2019

March

Media Release / Mar 26, 2019

Sandoz exclusively launches treprostinil injection, the first generic version of Remodulin®, in the US

Read More

February

Media Release / Feb 19, 2019

Sandoz launches authorized generic version of buprenorphine and naloxone sublingual film

Read More

January

Media Release / Jan 31, 2019

Sandoz US recognized as Top Employer for 2019

Read More
Media Release / Jan 24, 2019

Sandoz launches Desflurane, the first generic of Suprane®, in the US

Read More
Media Release / Jan 16, 2019

Sandoz Inc. launches SYMJEPI™ (epinephrine) in the US

Read More
Media Release / Jan 16, 2019

Sandoz selects three finalists for Healthcare Access Challenge (Sandoz HACk) from over 400 global entries

Read More
Media Release / Jan 07, 2019

Sandoz and Pear Therapeutics Announce US Launch of reSET-O™ to Help Treat Opioid Use Disorder

Read More
2018

December

Media Release / Dec 10, 2018

Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder

Read More
Media Release / Dec 06, 2018

Update on Launch Plans for SYMJEPI™ (epinephrine) in the US

Read More
Media Release / Dec 06, 2018

Sandoz biosimilar Zarxio™ (filgrastim-sndz) reduced out-of-pocket costs for Medicare patients with breast cancer versus the reference medicine

Read More